The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Brain : a journal of neurology

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/BRAIN/AWH054PMID 14662519
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

  2005cited by this paper
• L166P Mutant DJ-1, Causative for Recessive Parkinson's Disease, Is Degraded through the Ubiquitin-Proteasome System*

  2003cited by this paper
• Pathogenic role of glial cells in Parkinson's disease

  2003cited by this paper
• Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygen‐dependent mechanism

  2003cited by this paper
• The Crystal Structure of DJ-1, a Protein Related to Male Fertility and Parkinson's Disease*

  2003cited by this paper
• Selective degradation of oxidatively modified protein substrates by the proteasome.

  2003cited by this paper
• The role of pathogenic DJ‐1 mutations in Parkinson's disease

  2003influential reference
• Crystal Structures of Human DJ-1 and Escherichia coli Hsp31, Which Share an Evolutionarily Conserved Domain*

  2003cited by this paper
• Early‐onset Parkinson's disease caused by a compound heterozygous DJ‐1 mutation

  2003cited by this paper
• Rare genetic mutations shed light on the pathogenesis of Parkinson disease.

  2003cited by this paper
• Ubiquitin Conjugation Is Not Required for the Degradation of Oxidized Proteins by Proteasome*

  2003cited by this paper
• Pathways to Parkinsonism.

  2003influential reference
• Oxidative stress in Parkinson's disease

  2003cited by this paper
• Genes and parkinsonism.

  2003cited by this paper
• Crystal Structure of Human DJ-1, a Protein Associated with Early Onset Parkinson's Disease*

  2003cited by this paper
• Analysis of the Cytosolic Proteome in a Cell Culture Model of Familial Amyotrophic Lateral Sclerosis Reveals Alterations to the Proteasome, Antioxidant Defenses, and Nitric Oxide Synthetic Pathways*

  2003cited by this paper
• Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide.

  2002cited by this paper
• The role of astroglia on the survival of dopamine neurons

  2002cited by this paper
• Parkin Protects against the Toxicity Associated with Mutant α-Synuclein: Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons

  2002cited by this paper
• Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

  2002influential reference
• Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.

  2002influential reference
• Astrocytic but not neuronal increased expression and redistribution of parkin during unfolded protein stress

  2002cited by this paper
• Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.

  2002cited by this paper
• DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin

  2001cited by this paper
• The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders.

  2001cited by this paper
• Inhibition of 6-hydroxydopamine-induced p53 expression and survival of neuroblastoma cells following interaction with astrocytes.

  2001cited by this paper
• Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins

  2001cited by this paper
• DJ-1 Positively Regulates the Androgen Receptor by Impairing the Binding of PIASxα to the Receptor*

  2001influential reference
• Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat

  2001influential reference
• Proteasomal function is impaired in substantia nigra in Parkinson's disease.

  2001cited by this paper
• Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease

  2001cited by this paper
• Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

  2000cited by this paper
• An autopsy case of autosomal‐recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene

  2000cited by this paper
• A Drosophila model of Parkinson's disease

  2000cited by this paper
• Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

  2000cited by this paper
• A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.

  1999cited by this paper
• Immunohistochemical and subcellular localization of parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients

  1999cited by this paper
• Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q.

  1999cited by this paper
• Identification and characterization of a novel protein that regulates RNA–protein interaction

  1999cited by this paper
• The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.

  1999cited by this paper
• The ubiquitin pathway in Parkinson's disease

  1998cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998influential reference
• Molecular cloning and expression of rat contraception associated protein 1 (CAP1), a protein putatively involved in fertilization.

  1998cited by this paper
• Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q

  1998cited by this paper
• Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism

  1998cited by this paper
• alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

  1998cited by this paper
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

  1998cited by this paper
• α-Synuclein in Lewy bodies

  1997influential reference
• DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras.

  1997influential reference
• Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.

  1997cited by this paper
• Basic Fibroblast Growth Factor Stimulation of Glial Cells Protects Dopamine Neurons from 6‐Hydroxydopamine Toxicity: Involvement of the Glutathione System

  1997cited by this paper
• Genes and parkinsonism.

  1997influential reference
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Neuropathology of Parkinson's Disease

  1996cited by this paper
• Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

  1994cited by this paper
• Glutathione peroxidase, glial cells and Parkinson's disease.

  1993cited by this paper
• Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease.

  1992cited by this paper
• Astrocytes and Parkinson's disease.

  1992cited by this paper
• Ubiquitin carboxyl‐terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases

  1990cited by this paper
• Treatment of parkinsonism with levodopa.

  1969cited by this paper

• Early motor deficits, sleep dysfunction and reduction in dopaminergic neurons in a PARK7-/- zebrafish larval model of Parkinson's disease.

  2026cites this paper
• Cyflumetofen disrupts the blood-brain barrier and induces neurotoxicity in zebrafish larvae.

  2026cites this paper
• Immunity in Parkinson's disease - The role of innate responses.

  2025cites this paper
• Unbounded Cell Growth and Proteome Imbalance in Doxorubicin-Induced Senescent RPE-1 Cells

  2025cites this paper
• The Effect of Metformin on Astrocytes in Parkinson’s Disease: Challenges and Opportunities

  2025cites this paper
• Reduced DJ-1-F1Fo ATP synthase association correlates with midbrain dopaminergic neuron vulnerability in idiopathic Parkinson’s disease

  2025cites this paper
• DJ-1/PARK7 in Parkinson's disease: mechanisms of pathogenesis and therapeutic potential.

  2025cites this paper
• Single-cell sequencing and organoids: applications in organ development and disease

  2025cites this paper
• Synergistic blood-based diagnostic value of AP3B1 and BMPR2 in Parkinson’s disease

  2025cites this paper
• Deciphering the role of neuropeptides as biomarkers for early diagnosis of Parkinson's disease.

  2025cites this paper
• DJ-1 in Parkinson's disease: its important role at endoplasmic reticulum-mitochondria contact sites.

  2025cites this paper
• Natural pyrethrins induce cytotoxicity in SH-SY5Y cells and neurotoxicity in zebrafish embryos (Danio rerio).

  2024cites this paper
• Development and use of DJ-1 affinity microcolumns to screen and study small drug candidates for Parkinson's disease.

  2024cites this paper
• Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases.

  2024cites this paper
• Control of Dopamine Signal in High-Order Receptor Complex on Striatal Astrocytes

  2024cites this paper
• Knockdown of DJ-1 Exacerbates Neuron Apoptosis Induced by TgCtwh3 through the NF-κB Pathway

  2024influential citation
• Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model

  2024cites this paper
• LRP10 and α-synuclein transmission in Lewy body diseases

  2024cites this paper
• DJ‐1 regulates astrocyte activation through miR‐155/SHP‐1 signaling in cerebral ischemia/reperfusion injury

  2024cites this paper
• The immune system in Parkinson's disease: what we know so far

  2024cites this paper
• Protein modification in neurodegenerative diseases

  2024cites this paper
• Pathogenesis of DJ-1/PARK7-Mediated Parkinson’s Disease

  2024cites this paper
• Serum biomarkers in patients with drug-resistant epilepsy: a proteomics-based analysis

  2024cites this paper
• The Role of Astrocytes in Parkinson's Disease : Astrocytes in Parkinson's Disease.

  2024cites this paper
• DJ-1 mediates regulation of metabolism and immune response in Parkinson’s disease astrocytes and Glioblastoma cells

  2024cites this paper
• The autophagy protein Atg9 functions in glia and contributes to parkinsonian symptoms in a Drosophila model of Parkinson’s disease

  2023cites this paper
• RNA Binding Proteins in Senescence: A Potential Common Linker for Age-related Diseases?

  2023cites this paper
• Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges

  2023cites this paper
• A Review of Genetic and Gene Therapy for Parkinson’s Disease

  2023cites this paper
• LRP10 as a novel α-synuclein regulator in Lewy body diseases

  2023cites this paper
• Role of Astrocytes in Parkinson’s Disease Associated with Genetic Mutations and Neurotoxicants

  2023cites this paper
• Pazopanib ameliorates rotenone-induced Parkinsonism in rats by suppressing multiple regulated cell death mechanisms.

  2023cites this paper
• The reversible low‐temperature instability of human DJ‐1 oxidative states

  2023cites this paper
• The molecular mechanism of three novel peptides from C-phycocyanin alleviates MPTP-induced Parkinson's disease-like pathology in zebrafish.

  2023cites this paper
• The interplay between neuroinflammatory pathways and Parkinson's disease.

  2023cites this paper
• The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease

  2023cites this paper
• The Essential Role of Astrocytes in Neurodegeneration and Neuroprotection.

  2023cites this paper
• deCLUTTER2+ – a pipeline to analyze calcium traces in a stem cell model for ventral midbrain patterned astrocytes

  2023cites this paper
• Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.

  2023cites this paper
• Early resource scarcity causes cortical astrocyte enlargement and sex-specific changes in the orbitofrontal cortex transcriptome in adult rats

  2023cites this paper
• Salivary Biomarkers: Noninvasive Ways for Diagnosis of Parkinson's Disease

  2023cites this paper
• PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target

  2023cites this paper
• Neuroprotection of Thioredoxin1 in the brain.

  2023cites this paper
• Skeletal muscle‐specific DJ‐1 ablation‐induced atrogenes expression and mitochondrial dysfunction contributing to muscular atrophy

  2023cites this paper
• Recent progress and challenges in the application of molecularly imprinted polymers for early-stage screening of neurodegenerative diseases-related protein biomarkers

  2023cites this paper
• Repurposed anti-cancer epidermal growth factor receptor inhibitors: mechanisms of neuroprotective effects in Alzheimer’s disease

  2022cites this paper
• Neuroprotective effect of YIAEDAER peptide against Parkinson's disease like pathology in zebrafish.

  2022cites this paper
• Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson's disease like pathology in Zebrafish.

  2022cites this paper
• Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?

  2022influential citation
• Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease

  2022cites this paper
• Vascular smooth muscle cell dysfunction in neurodegeneration

  2022cites this paper
• Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective

  2022cites this paper
• NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson’s Disease

  2022cites this paper
• Disruption of lysosomal proteolysis in astrocytes facilitates midbrain proteostasis failure in an early-onset PD model

  2022influential citation
• DJ-1 controls T cell differentiation and osteoclastogenesis in rheumatoid arthritis

  2022cites this paper
• Chemical Toolkit for PARK7: Potent, Selective, and High-Throughput

  2022cites this paper
• Redox-sensitive DJ-1 protein: An insight into physiological roles, secretion, and therapeutic target

  2022cites this paper
• Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease

  2022cites this paper
• Application of explainable artificial intelligence in the identification of Squamous Cell Carcinoma biomarkers

  2022cites this paper
• Impact of Single Amino Acid Substitutions in Parkinsonism-Associated Deglycase-PARK7 and Their Association with Parkinson’s Disease

  2022influential citation
• Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives

  2022cites this paper
• Pyruvate Dehydrogenase Kinase Protects Dopaminergic Neurons from Oxidative Stress in Drosophila DJ-1 Null Mutants

  2022cites this paper
• Autophagy and Glycative Stress: A Bittersweet Relationship in Neurodegeneration

  2021cites this paper
• A New Insight into an Alternative Therapeutic Approach to Restore Redox Homeostasis and Functional Mitochondria in Neurodegenerative Diseases

  2021cites this paper
• The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention

  2021cites this paper
• Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?

  2021cites this paper
• Dictyostelium discoideum as a Model for Investigating Neurodegenerative Diseases

  2021cites this paper
• Reintroduction of DJ-1 in Müller Cells Inhibits Retinal Degeneration in the DJ-1 Deficient Retina

  2021cites this paper
• Recent approaches to target apoptosis in neurological disorders

  2021cites this paper
• Parkinson's in the bone

  2021cites this paper
• DJ-1 in neurodegenerative diseases: pathogenesis and clinical application.

  2021cites this paper
• A pH-eQTL Interaction at the RIT2–SYT4 Parkinson’s Disease Risk Locus in the Substantia Nigra

  2021cites this paper
• Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation

  2021cites this paper
• Astrocyte-Neuron Metabolic Crosstalk in Neurodegeneration: A Mitochondrial Perspective

  2021cites this paper
• The role of oxidative stress and the underlying biological pathways in the pathogenesis of Parkinson’s Disease

  2021cites this paper
• Protein deglycase DJ‐1 deficiency induces phenotypic switching in vascular smooth muscle cells and exacerbates atherosclerotic plaque instability

  2021cites this paper
• Neurodegeneration: Impact of S-nitrosylated Parkin, DJ-1 and PINK1 on Parkinson's disease.

  2021cites this paper
• The Role of DJ-1 in Cellular Metabolism and Pathophysiological Implications for Parkinson’s Disease

  2021cites this paper
• AAV Targeting of Glial Cell Types in the Central and Peripheral Nervous System and Relevance to Human Gene Therapy

  2021cites this paper
• Contribution of astrocytes to neuropathology of neurodegenerative diseases.

  2021cites this paper
• Mitochondrial ATP-Dependent Proteases—Biological Function and Potential Anti-Cancer Targets

  2021cites this paper
• DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein

  2021cites this paper
• NLR in eXile: Emerging roles of NLRX1 in immunity and human disease

  2020cites this paper
• Aspek genetik dan manifestasi klinis varian young onset Parkinson disease

  2020cites this paper
• Pathological Functions of LRRK2 in Parkinson’s Disease

  2020cites this paper
• Neuron-Astrocyte Interactions in Parkinson’s Disease

  2020cites this paper
• Protein interaction studies for understanding the tremor pathway in Parkinson's disease.

  2020cites this paper
• Identification of Disease-Associated Variants by Targeted Gene Panel Resequencing in Parkinson's Disease

  2020cites this paper
• DJ-1 in astrocytic neuroprotection to oxidative stress

  2020cites this paper
• A systems biology approach for studying neurodegenerative diseases.

  2020cites this paper
• Chaperones and Proteostasis: Role in Parkinson’s Disease

  2020cites this paper
• Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications

  2020cites this paper
• Understanding the pathogenesis involved in Parkinson's disease and potential therapeutic treatment strategies.

  2020cites this paper
• Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson’s Disease

  2020cites this paper
• Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries

  2020cites this paper
• Microglia and astrocyte dysfunction in parkinson's disease.

  2020cites this paper
• Association between a DJ-1 polymorphism and the risk of Parkinson's disease: a PRISMA-compliant systematic review and meta-analysis

  2020cites this paper
• Genetic targeting of astrocytes to combat neurodegenerative disease

  2019cites this paper
• Role of Astrocytes in Manganese Neurotoxicity Revisited

  2019cites this paper
• Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease

  2019cites this paper